XCures, a startup specializing in AI-driven medical records management, closed a $46 million Series B round led by Innovius Capital, aiming to resolve challenges in chaotic patient data and improve clinical decision-making across US healthcare providers.
- XCures uses AI to clean and structure disorganized patient data
- Company’s valuation more than doubled since last round in 2023
- Supports clinical decisions for millions with data from over 550,000 locations
What happened
XCures secured $46 million in a Series B financing round led by Innovius Capital, with participation from iGrow, Spring Mountain Capital, and existing investors. This financing round brings the startup’s total funding to over $76 million since its founding in 2018 and values the company at $127 million post-money, more than twice the valuation from its Series A round in December 2023.
Originally launched as a spinout from Cancer Commons, XCures initially focused on providing decision-support tools for patients with late-stage cancer. However, the company encountered significant challenges in accessing and managing patient records, which often arrived in physical or unusable digital formats. This motivated a pivot to building infrastructure that connects to national healthcare interoperability networks and converts complex medical data into actionable clinical intelligence.
Why it matters
The healthcare sector has long struggled with fragmented and unstructured patient data, making it difficult for clinicians to obtain clear, actionable information. XCures addresses this critical pain point by transforming 'dirty' data—including duplicated entries, scanned documents, and narrative notes—into structured, evidence-grade formats that support clinical workflows and decision-making.
Their proprietary Clinical Clarity Engine automates the generation of decision-ready patient history checklists, leveraging a mix of AI technologies tailored for the healthcare domain. By integrating with numerous healthcare data sources nationwide, XCures significantly enhances the usability of patient records, potentially improving outcomes and efficiency in clinical settings.
What to watch next
With this fresh capital, XCures is positioned to expand its reach and technology capabilities, scaling its infrastructure to manage even larger volumes of patient data. Investors’ growing enthusiasm for AI-powered health tech underscores the potential impact of startups like XCures in transforming healthcare data management.
Market observers should watch how XCures’ technology adoption spreads across different healthcare organizations and whether it can maintain its technology lead. Additionally, regulatory developments around data interoperability and patient data privacy will be important factors influencing XCures' future growth and integration within the US healthcare ecosystem.